Research indicates that in AP, interventions targeting the modulation of LC3 and p62/SQSTM1 expression can enhance autophagy and mitigate pathological harm to the pancreas (113, 114). This evidence concerns the gene SQSTM1 and alkaline phosphatase measurement.